Comments
Healthcare player, Cadila Healthcare (Zydus Cadila), posted a standalone net profit of Rs 338 crore in the quarter ended March 2016, which is a marginal decline of 2 per cent on the Rs 347 crore posted in the corresponding quarter a year ago.
The company's standalone income from operations stood at Rs 1,429 crore for the quarter as against Rs 1,454 crore in the same period last year.
For the full year, the company's net profit on a standalone basis stood at Rs 1,977 crore, which is 55 per cent higher than the Rs 1,271 crore recorded last year. Total income stood at Rs 7,035 crore for the year under review against Rs 5,284 crore last year.
On a consolidated basis, the company's net profit for the quarter ended March 2016 stood at Rs 389 crore, up 11 per cent from the Rs 350 crore in the corresponding quarter last year. The total consolidated income for the quarter stood at Rs 2,449 crore, against Rs 2,288 crore last year.
For the full year, consolidated net profit was up by 32 per cent at Rs 1,523 crore as against Rs 1,151 crore in the previous year. Consolidated total income from operations grew by 14 per cent during the year to Rs 9,838 crore from Rs 8,651 crore last year.
Cadila Healthcare shares fell by over 2 per cent on Friday to close at Rs 326.10 on the National Stock Exchange (NSE).
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.